Integrated Filing — IndAS

General information about company
Scrip Code	530079
NSE Symbol	FAZE3Q
MSEI Symbol	NOTLISTED
ISIN	INE963C01033
Name of company	Faze Three Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	23-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	17-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Manufacturing of Home Textile Products
Start date and time of board meeting	23-May-2025   17:00:00
End date and time of board meeting	23-May-2025   17:55:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-05-23
Indicate Company website link for updated RPT policy of the Company	https://www.fazethree.com/investors/policies
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
The Company has not defaulted on any of its loans. Furthermore, the Company has not issued any debt securities.

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1987900000	6589100000
	Other income	83900000	140200000
	Total income	2071800000	6729300000
2	Expenses
(a)	Cost of materials consumed	977000000	3518200000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	10700000	-292200000
(d)	Employee benefit expense	292700000	1021200000
(e)	Finance costs	38700000	142700000
(f)	Depreciation, depletion and amortisation expense	65000000	240300000
(f)	Other Expenses
1	Other expenses	481600000	1584900000
	Total other expenses	481600000	1584900000
	Total expenses	1865700000	6215100000
3	Total profit before exceptional items and tax	206100000	514200000
4	Exceptional items	0	0
5	Total profit before tax	206100000	514200000
6	Tax expense
7	Current tax	30900000	98700000
8	Deferred tax	5300000	17200000
9	Total tax expenses	36200000	115900000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	169900000	398300000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	169900000	398300000
17	Other comprehensive income net of taxes	2800000	-2800000
18	Total Comprehensive Income for the period	172700000	395500000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	243200000	243200000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		3407600000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	6.99	16.38
	Diluted earnings (loss) per share from continuing operations	6.99	16.38
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	6.99	16.38
	Diluted earnings (loss) per share from continuing and discontinued operations	6.99	16.38
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		1. The Company is engaged in manufacturing and exports of home textiles products items viz. bathmats, rugs, blankets, throws, cushions, etc. n n2. The Statement of audited Standalone Financial Results were reviewed and recommended by the Audit Committee and thereafter approved by the Board of Directors at their respective meetings held on May 23, 2025. n nThe standalone financial results of the Company, will be available on the website of BSE (www.bseindia.com) and NSE (www.nseindia.com) and on Company's website (www.fazethree.com). n n3. The above Statement has been prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 ‘Interim Financial Reporting’, prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder and in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended. n n4. The Shareholders of the Company, by resolutions passed at 39th Annual General Meeting of the Company held on 27th September 2024, approved, inter alia, acquisition of equity shares by Faze Three Employee Trust (“Trust”) for implementation of Faze Three Employee Stock Options Scheme – 2024 ('ESOP 2024'). Trust was formed with objects of welfare of employees of the Company, inter alia, by way of acquiring, holding and allocating 10,94,355 (Ten Lakhs Ninety Four Thousand Three Hundred and Fifty Five) Equity Shares (‘Shares’). No options have been so far granted to any of the eligible employee or director. n nThe financial results of the Trust have been included in the standalone and consolidated financial results of the Company in accordance with the requirements of Ind-AS and cost of such Treasury shares has been presented as a deduction in Other Equity. Such number of equity shares (which are lying with the Trust) have been reduced while computing basic and diluted earnings per share. n n5. The Company operates in only one reportable segment viz. manufacturing of home textiles. n n6. There is no dilution to the basic EPS as there are no outstanding potentially dilutive shares. n n7. The Audited Standalone financial results are rounded to the nearest crores, except when otherwise indicated. Amounts represented by ‘0’ (zero) construes value less than Rupees fifty thousand. n n8. The Audited Standalone financial results for the three months ended March 31, 2025 and March 31, 2024 are the balancing figures between the Audited figures for the full financial year then ended and year to date figures up to the third quarter of the respective financial years, which was subject to limited review. n n9. The figures for the previous period/year have been regrouped / reclassified wherever necessary, to make them comparable. n

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	2786600000
	Capital work-in-progress	74800000
	Investment property	0
	Goodwill	0
	Other intangible assets	1700000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	26700000
	Trade receivables, non-current	0
	Loans, non-current	383200000
	Other non-current financial assets	32400000
	Total non-current financial assets	442300000
	Deferred tax assets (net)	0
	Other non-current assets	102200000
	Total non-current assets	3407600000
2	Current assets
	Inventories	1859500000
	Current financial asset
	Current investments	105100000
	Trade receivables, current	808300000
	Cash and cash equivalents	88300000
	Bank balance other than cash and cash equivalents	1800000
	Loans, current	0
	Other current financial assets	52700000
	Total current financial assets	1056200000
	Current tax assets (net)	0
	Other current assets	355600000
	Total current assets	3271300000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	6678900000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	243200000
	Other equity	3924500000
	Total equity attributable to owners of parent	4167700000
	Non controlling interest
	Total equity	4167700000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	59600000
	Total non-current financial liabilities	59600000
	Provisions, non-current	19400000
	Deferred tax liabilities (net)	76800000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	155800000
	Current liabilities
	Current financial liabilities
	Borrowings, current	1685700000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	64500000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	326000000
	Total Trade payable	390500000
	Other current financial liabilities	218100000
	Total current financial liabilities	2294300000
	Other current liabilities	13500000
	Provisions, current	43700000
	Current tax liabilities (Net)	3900000
	Deferred government grants, Current	0
	Total current liabilities	2355400000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	2511200000
	Total equity and liabilites	6678900000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurement of the post employment defined benefit plans	3800000	-3700000
2	Tax relating to items that will not be reclassified to profit or loss	-1000000	900000
	Total Amount of items that will not be reclassified to profit and loss	2800000	-2800000
2	Income tax relating to items that will not be reclassified to profit or loss	0	0
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	2800000	-2800000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			514200000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			142700000
	Adjustments for decrease (increase) in inventories			-591500000
	Adjustments for decrease (increase) in trade receivables, current			-58400000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-82000000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			6600000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			234500000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			2500000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			240300000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			4400000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			53400000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			26500000
	Adjustments for dividend income			0
	Adjustments for interest income			37000000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-22000000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-76300000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-156300000
	Net cash flows from (used in) operations			357900000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			70400000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			287500000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			107300000
	Purchase of property, plant and equipment			746000000
	Proceeds from sales of investment property			410900000
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			256700000
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			31800000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) investing activities	-452700000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			119800000
	Repayments of borrowings			0
	Payments of lease liabilities			52500000
	Dividends paid			0
	Interest paid			131300000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-10000000
	Net cash flows from (used in) financing activities			-74000000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-239200000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			-26900000
	Net increase (decrease) in cash and cash equivalents			-266100000
	Cash and cash equivalents cash flow statement at beginning of period			354400000
	Cash and cash equivalents cash flow statement at end of period			88300000